STOCK TITAN

Upexi (UPXI) grants CFO 400,000 restricted shares vesting through 2027

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Norstrud Andrew James reported acquisition or exercise transactions in this Form 4 filing.

Upexi, Inc. reported that Chief Financial Officer and director Andrew James Norstrud received a grant of 400,000 shares of restricted common stock under the company’s 2019 Incentive Stock Plan. These shares vest in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service. Following this award, Norstrud beneficially owns 1,049,138 shares of Upexi common stock.

Positive

  • None.

Negative

  • None.
Insider Norstrud Andrew James
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Common Stock F1 400,000 $0.00 --
Holdings After Transaction: Common Stock — 1,049,138 shares (Direct)
Footnotes (1)
  1. F1. Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service.
Restricted stock granted 400,000 shares Grant of common stock to CFO Andrew James Norstrud
Per-share grant price $0.0000 Reported price for the restricted stock grant
Shares owned after grant 1,049,138 shares Total common shares beneficially owned following the award
Vesting dates Oct 1 2026; Jan 1 2027; Apr 1 2027; Jul 1 2027 Restricted stock vests in four equal installments, subject to continued service
restricted stock financial
"Represents restricted stock granted pursuant to the Issuer's 2019 Incentive"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
2019 Incentive Stock Plan financial
"granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended"
vests in four equal installments financial
"that vests in four equal installments on October 1, 2026, January 1, 2027"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Upexi (UPXI) disclose for CFO Andrew James Norstrud?

Upexi disclosed that CFO Andrew James Norstrud received a grant of 400,000 shares of restricted common stock. The award was made under the company’s 2019 Incentive Stock Plan and increases his total beneficial ownership to 1,049,138 shares.

How many Upexi (UPXI) shares does the CFO own after this restricted stock grant?

After the grant, CFO Andrew James Norstrud beneficially owns 1,049,138 shares of Upexi common stock. This figure includes the newly granted 400,000 restricted shares, which will vest over time subject to his continued service.

When do the 400,000 restricted Upexi (UPXI) shares granted to the CFO vest?

The 400,000 restricted shares vest in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027. Vesting is subject to continued service with the company.

What plan governs the new restricted stock award reported by Upexi (UPXI)?

The award is granted under Upexi’s 2019 Incentive Stock Plan, as amended. This plan provides for equity-based compensation, including restricted stock, to align management’s interests with shareholders over a multi-year vesting period.

Was the Upexi (UPXI) CFO’s restricted stock grant a market purchase?

No. The filing characterizes the transaction as a grant or award acquisition of restricted stock at a reported price of $0.0000 per share, indicating it is compensation-related rather than a purchase on the open market.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Norstrud Andrew James

(Last)(First)(Middle)
3030 N ROCKY POINT DRIVE
STE. 420

(Street)
TAMPA FLORIDA 33607

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UPEXI, INC. [ UPXI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/03/2026A400,000(1)A$01,049,138D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service.
/s/ Andrew Norstrud07/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)